S&P's Top Biotech Beneficiaries of Health Care Reform – DailyFinance
If the health bills in Congress become law, the biotech sector may become one of the biggest beneficiaries of the reform. Standard.
See original here:
S&P's Top Biotech Beneficiaries of Health Care Reform – DailyFinance
